)
The cell and gene therapy sector acknowledges the imperative of automation, yet progress is often hindered by a complex web of challenges.
Building on our previous discussion of these initial barriers, this roundtable moves beyond simply identifying obstacles.
We'll dive deep into practical strategies for achieving tangible returns on automation investments and navigating the intricacies of implementation.
Join your peers to explore how to translate the promise of automation into real-world success, accelerating your journey towards scalable and efficient cell therapy manufacturing.
This core segment of the virtual roundtable delves into the predetermined topic, facilitated by the moderator. Participants are encouraged to share insights, experiences, and perspectives, fostering a rich, collaborative dialogue. This hour-long discussion aims to share common challenges, explore solutions, trends, and innovative ideas.
2410 virtual roundtables are an exclusive forum that bring together life science executives to engage in candid discussion, share insight and collaborate on common challenges facing cell therapy developers today.
Facilitated by Michael Adeniya, an events strategist with 15+ years in advanced therapies, you'll be an active participant in the discussion.
You'll leave with practical strategies to implement in your organization.
Enhance your approach and drive growth with insights gained from the roundtable. All gained from the comfort of your own office!
Adva Biotechnology was established in 2016 with the vision of "Valuing life by granting advanced therapies to patients".
Knowing the need for smart and adaptive automation, and understanding that processes change and varies, the Adva Biotechnology team developed a simple, smart, easy to use, automated, sensors-based, flexible platform.
AdvaX3 enables full manufacturing process of different applications, such as CAR-T, TCR, TILs, NK, Exosomes, viruses, and more. By that, the AdvaX3 brings different therapies to the bedside.
In order to facilitate a rich discussion, each roundtable is limited to only 6 participants and is not recorded.
If you're unable to attend this one, contact us keep informed about future roundtables. michael@2410.consulting